Skip to main content
. 2022 Jun 16;9:851833. doi: 10.3389/fcvm.2022.851833

TABLE 1.

Demographic and clinicopathological characteristics of the included CRC patients.

Characteristics Number (%)
Total 197,699
Year of diagnosis
2007–2010 89,006 (45.0)
2011–2015 108,693 (55.0)
Age
<65 98,682 (49.9)
≥65 99,017 (50.1)
Sex
Female 95,030 (48.1)
Male 102,669 (51.9)
Race
Black 23,557 (11.9)
White 156,015 (78.9)
Other 18,127 (9.2)
Marital status
Married 111,210 (56.3)
Unmarried 86,489 (43.7)
Insurance
Any Medicaid 24,892 (12.6)
Insured 165,937 (83.9)
Uninsured 6,870 (3.5)
Tumor site
Left 101,144 (51.2)
Right 93,632 (47.4)
NOS 2,923 (1.5)
Tumor size
≤5 cm 112,065 (56.7)
5–10 cm 52,078 (26.3)
>10 cm 33,556 (17.0)
Grade
Grade I 21,461 (10.9)
Grade II 137,501 (69.6)
Grade III 33,300 (16.8)
Grade IV 5,437 (2.8)
SEER stage
Localized 77,655 (39.3)
Regional 81,662 (41.3)
Distant 38,382 (19.4)
Surgery
No 18,599 (9.4)
Yes 179,100 (90.6)
Radiotherapy
No 168,962 (85.5)
Yes 28,737 (14.5)
Chemotherapy
No 115,753 (58.6)
Yes 81,946 (41.4)
Causes
Alive 118,244 (59.8)
Death form CRC 9,702 (4.9)
Death form CVD 56,185 (28.4)
Death form non-CVD 13,568 (6.9)

Other, American Indian/Alaska Native/Asian/Pacific Islander; NOS, not otherwise specified; SEER, Surveillance, Epidemiology, and End Results; CRC, colorectal cancer; CVD, cardiovascular death.